- Home
- LEGN vs CIGI Comparison
LEGN vs CIGI Comparison
Compare LEGN & CIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- CIGI
- Stock Information
- Founded
- LEGN 2014
- CIGI 1972
- Country
- LEGN United States
- CIGI Canada
- Employees
- LEGN N/A
- CIGI N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- CIGI
- Sector
- LEGN Health Care
- CIGI
- Exchange
- LEGN Nasdaq
- CIGI Nasdaq
- Market Cap
- LEGN 7.0B
- CIGI 5.8B
- IPO Year
- LEGN 2020
- CIGI N/A
- Fundamental
- Price
- LEGN $31.78
- CIGI $123.65
- Analyst Decision
- LEGN Strong Buy
- CIGI Buy
- Analyst Count
- LEGN 13
- CIGI 7
- Target Price
- LEGN $79.42
- CIGI $157.43
- AVG Volume (30 Days)
- LEGN 1.5M
- CIGI 104.0K
- Earning Date
- LEGN 05-13-2025
- CIGI 05-06-2025
- Dividend Yield
- LEGN N/A
- CIGI 0.24%
- EPS Growth
- LEGN N/A
- CIGI 39.07
- EPS
- LEGN N/A
- CIGI 2.86
- Revenue
- LEGN $627,241,000.00
- CIGI $4,961,214,000.00
- Revenue This Year
- LEGN $65.96
- CIGI $12.96
- Revenue Next Year
- LEGN $52.55
- CIGI $7.07
- P/E Ratio
- LEGN N/A
- CIGI $42.86
- Revenue Growth
- LEGN 119.97
- CIGI 13.50
- 52 Week Low
- LEGN $29.27
- CIGI $100.86
- 52 Week High
- LEGN $60.87
- CIGI $156.96
- Technical
- Relative Strength Index (RSI)
- LEGN 41.49
- CIGI 59.52
- Support Level
- LEGN $30.25
- CIGI $114.92
- Resistance Level
- LEGN $35.81
- CIGI $122.68
- Average True Range (ATR)
- LEGN 1.45
- CIGI 2.94
- MACD
- LEGN -0.18
- CIGI 1.13
- Stochastic Oscillator
- LEGN 27.58
- CIGI 96.83
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About CIGI Colliers International Group Inc. Subordinate Voting Shares
Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are; Real Estate Services, Engineering, Investment Management, and Corporate. Maximum revenue for the company is generated from its Real Estate Services segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, property sales brokerage, and lease brokerage services, among others. Geographically, the company generates maximum revenue from the United States and the rest from Canada, Australia, the United Kingdom, Poland, China, India, and other regions.